{"title":"Comparison of two RP-HPLC methods for determination of recombinant human thrombin in pharmaceutical formulations. / Porovnanie dvoch RP-HPLC metód pre stanovenie rekombinantného ľudského trombínu vo farmaceutických formuláciách","authors":"P. Bartos, A. Murányi, M. Šnauko","doi":"10.1515/afpuc-2015-0001","DOIUrl":null,"url":null,"abstract":"Abstract Two reversed-phase high performance liquid chromatography analytical methods (Method I and Method II) for determination of assay of recombinant human thrombin in pharmaceutical formulations were developed and validated. Analysis was performed on chromatographic system Agilent 1200 series SL with diode array detection and mass selective detection. Method I was intended for faster determination of thrombin assay. Gradient programme was optimised to achieve sufficient separation and acceptable runtime. Chromatographic analysis was performed on analytical column Grace Vydac, C4 250 × 4.6 mm, 5 mm. Method II is Method I adapted to use the mass selective detector. Chromatographic separation was performed on analytical column Zorbax 300SB-C8 SolvSaver Plus, 150 × 3 mm, 3.5 mm. Both analytical methods were validated with respect to specificity, linearity, precision and accuracy. The response of thrombin was a linear function of concentration over the range 0.1-1.0 mg/ml. Precision and accuracy of thrombin was evaluated at three concentration levels low (0.2 mg/ml), medium (0.4 mg/ml) and high (0.8 mg/ml). Both validated methods have been successfully applied for determination of assay and thrombin degradation products in pharmaceutical formulations. Slovak abstract Na stanovenie obsahu rekombinantneho ľudskeho trombinu boli vyvinute a validovane dve analyticke metody (Metoda I a Metoda II). Analyzy boli uskutočnene na chromatografickom systeme Agilent 1200 series SL s DAD a MS detektorom. Metoda I je určena pre rychlejšiu analyzu obsahu trombinu. Pre dosiahnutie lepšej separacie a prijateľneho času analyzy bol optimalizovany gradientovy program. Chromatograficka separacia sa uskutočnila na analytickej kolone Grace Vydac, C4 250x4.6mm, 5mm. Metoda II bola odvodena od Metody I tak aby bola použiteľna v kombinacii s hmotnostnym detektorom. Chromatograficka separacia sa uskutočnila na analytickej kolone Zorbax 300SB-C8 Solv Saver Plus, 150x3mm, 3.5mm. U oboch metod boli validovane nasledujuce parametre: špecificita, linearita, presnosť a spravnosť. Odozva trombinu bola linearnou funkciou koncentracie v rozsahu od 0,1 do 1,0 mg/ml. Presnosť a spravnosť trombinu bola hodnotena pri troch koncentračnych hladinach: nizkej (0,2 mg/ml), strednej (0,4 mg/ml) a vysokej (0,8 mg/ml). Robustne validovane metody boli uspešne použite pri stanoveni obsahu a čistoty trombinu počas formulačneho vyvoja liekovej formy.","PeriodicalId":7321,"journal":{"name":"Acta Facultatis Pharmaceuticae Universitatis Comenianae","volume":"193 1","pages":"31 - 39"},"PeriodicalIF":0.0000,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Facultatis Pharmaceuticae Universitatis Comenianae","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/afpuc-2015-0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
建立了两种反相高效液相色谱法(方法一和方法二)测定复方中重组人凝血酶含量的方法,并进行了验证。分析采用安捷伦1200系列SL色谱系统,采用二极管阵列检测和质量选择检测。方法一为快速测定凝血酶含量而设计。对梯度程序进行了优化,以达到充分的分离和可接受的运行时间。色谱柱为Grace Vydac, C4 250 × 4.6 mm, 5 mm。方法二是方法一适用于质量选择检测器。色谱柱为Zorbax 300SB-C8 SolvSaver Plus, 150 × 3 mm, 3.5 mm。验证了两种分析方法的特异性、线性度、精密度和准确度。在0.1 ~ 1.0 mg/ml范围内,凝血酶的反应与浓度呈线性关系。在低(0.2 mg/ml)、中(0.4 mg/ml)和高(0.8 mg/ml)三个浓度水平下评价凝血酶的精密度和准确度。两种验证的方法已成功地应用于测定制剂中的化验和凝血酶降解产物。斯洛伐克摘要Na stanovenie obsahu rekombinantneho ľudskeho trombinu boli vyvinte是一种有效的分析方法(Metoda I和Metoda II)。分析boli使用的是 nene Na色谱分析系统Agilent 1200系列SL - DAD和MS检测器。方法1 [j] [j] [j] [j] [e] [rychlejšiu]。Pre - dose - hnuuinlepšej separation and prijateľneho - asu analysis bol optimization of ovany graditovy program。色谱分离技术应用于 nila - na分析关键字kolone Grace Vydac, C4 250x4.6mm, 5mm。Metoda II流星锤odvodena od Metody我德赎流星锤použ尽管ľna v kombinacii年代hmotnostnym detektorom。色谱分离技术应用于 nila na分析技术,kolone Zorbax 300SB-C8 Solv Saver Plus, 150x3mm, 3.5mm。这两种方法均有效地验证了鼻窦炎参数:špecificita、linearita、presnosva、spravnosva。Odozva - trobbinu曲线线性,现测定其浓度为0、1、1、0 mg/ml。presnosova spravnosovtrombinu bola hodnotena prtroch koncentra: nizkej (0.2 mg/ml), strednej (0.4 mg/ml)和vysokej (0.8 mg/ml)。稳健有效的方法boli uspešne použite pri stanoveni obsahu和历史上从配方中提取的蛋白质 [j] [j]。
Comparison of two RP-HPLC methods for determination of recombinant human thrombin in pharmaceutical formulations. / Porovnanie dvoch RP-HPLC metód pre stanovenie rekombinantného ľudského trombínu vo farmaceutických formuláciách
Abstract Two reversed-phase high performance liquid chromatography analytical methods (Method I and Method II) for determination of assay of recombinant human thrombin in pharmaceutical formulations were developed and validated. Analysis was performed on chromatographic system Agilent 1200 series SL with diode array detection and mass selective detection. Method I was intended for faster determination of thrombin assay. Gradient programme was optimised to achieve sufficient separation and acceptable runtime. Chromatographic analysis was performed on analytical column Grace Vydac, C4 250 × 4.6 mm, 5 mm. Method II is Method I adapted to use the mass selective detector. Chromatographic separation was performed on analytical column Zorbax 300SB-C8 SolvSaver Plus, 150 × 3 mm, 3.5 mm. Both analytical methods were validated with respect to specificity, linearity, precision and accuracy. The response of thrombin was a linear function of concentration over the range 0.1-1.0 mg/ml. Precision and accuracy of thrombin was evaluated at three concentration levels low (0.2 mg/ml), medium (0.4 mg/ml) and high (0.8 mg/ml). Both validated methods have been successfully applied for determination of assay and thrombin degradation products in pharmaceutical formulations. Slovak abstract Na stanovenie obsahu rekombinantneho ľudskeho trombinu boli vyvinute a validovane dve analyticke metody (Metoda I a Metoda II). Analyzy boli uskutočnene na chromatografickom systeme Agilent 1200 series SL s DAD a MS detektorom. Metoda I je určena pre rychlejšiu analyzu obsahu trombinu. Pre dosiahnutie lepšej separacie a prijateľneho času analyzy bol optimalizovany gradientovy program. Chromatograficka separacia sa uskutočnila na analytickej kolone Grace Vydac, C4 250x4.6mm, 5mm. Metoda II bola odvodena od Metody I tak aby bola použiteľna v kombinacii s hmotnostnym detektorom. Chromatograficka separacia sa uskutočnila na analytickej kolone Zorbax 300SB-C8 Solv Saver Plus, 150x3mm, 3.5mm. U oboch metod boli validovane nasledujuce parametre: špecificita, linearita, presnosť a spravnosť. Odozva trombinu bola linearnou funkciou koncentracie v rozsahu od 0,1 do 1,0 mg/ml. Presnosť a spravnosť trombinu bola hodnotena pri troch koncentračnych hladinach: nizkej (0,2 mg/ml), strednej (0,4 mg/ml) a vysokej (0,8 mg/ml). Robustne validovane metody boli uspešne použite pri stanoveni obsahu a čistoty trombinu počas formulačneho vyvoja liekovej formy.